UBS Group’s Oculis Holding AG Warrants OCSAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.5K Buy
300
+30
+11% +$351 ﹤0.01% 9534
2026
Q1
$4.05K Buy
270
+100
+59% +$1.55K ﹤0.01% 8997
2025
Q4
$1.46K Hold
170
﹤0.01% 9580
2025
Q3
$1.15K Hold
170
﹤0.01% 9422
2025
Q2
$1.33K Sell
170
-320
-65% -$2.26K ﹤0.01% 9637
2025
Q1
$3.7K Buy
+490
New +$4.59K ﹤0.01% 9187
2024
Q3
Sell
-9,652
Closed -$17.9K 9908
2024
Q2
$17.9K Buy
+9,652
New +$20K ﹤0.01% 7371

Other funds holding OCSAW

UBS Group's OCSAW Position: Q2 2026 in Review

UBS Group increased its Oculis Holding AG Warrants (OCSAW) stake by 11% in Q2 2026, buying an estimated $351 and bringing the position to 300 shares worth $1.5K. The position accounts for ﹤0.01% of the portfolio, ranked #9534.

UBS Group first reported a position in OCSAW in Q2 2024 and has held it in 7 quarters since. The position peaked at $17.9K in Q2 2024. 8 funds tracked by Wall St. Rank hold OCSAW as of Q2 2026.

  • UBS Group held 300 shares of Oculis Holding AG Warrants worth $1.5K as of Q2 2026.
  • UBS Group bought 30 Oculis Holding AG Warrants shares in Q2 2026, an estimated $351.
  • Oculis Holding AG Warrants made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #9534 holding.
  • UBS Group first reported a position in Oculis Holding AG Warrants in Q2 2024 and has held it in 7 quarters since.
  • UBS Group's Oculis Holding AG Warrants position peaked at $17.9K in Q2 2024.
  • 8 funds tracked by Wall St. Rank held Oculis Holding AG Warrants as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.